Your browser doesn't support javascript.
loading
The prognostic landscape of interactive biological processes presents treatment responses in cancer.
He, Bin; Gao, Rui; Lv, Dekang; Wen, Yalu; Song, Luyao; Wang, Xi; Lin, Suxia; Huang, Qitao; Deng, Ziqian; Wang, Zifeng; Yan, Min; Zheng, Feimeng; Lam, Eric W-F; Kelley, Keith W; Li, Zhiguang; Liu, Quentin.
Afiliación
  • He B; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.
  • Gao R; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, PR China; Department of Medical Oncology, The Seventh Affili
  • Lv D; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, PR China.
  • Wen Y; Department of Statistics, University of Auckland, New Zealand.
  • Song L; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, PR China.
  • Wang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.
  • Lin S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.
  • Huang Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.
  • Deng Z; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, PR China.
  • Wang Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.
  • Yan M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China.
  • Zheng F; Department of Medical Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510060, PR China.
  • Lam EW; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital Campus, London, W12 ONN, UK.
  • Kelley KW; Laboratory of Immunophysiology, Department of Animal Sciences, College of ACES and Department of Pathology, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, USA.
  • Li Z; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, PR China. Electronic address: zhiguangli2013@126.com.
  • Liu Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China; Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, PR China. Electronic address: liuq9@mail.sysu.edu.cn.
EBioMedicine ; 41: 120-133, 2019 Mar.
Article en En | MEDLINE | ID: mdl-30799199
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Transcriptoma / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Transcriptoma / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos